Morinaga Milk Industry Co. Ltd., Japan   Report issue

For profit Phase 1 Phase 3
Founded: Tokyo Japan (1917)
Status: No NME R&D (1917)

Organization Overview

First Clinical Trial
2015
NCT02434042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Morinaga Milk Industry Co., LTD | Morinaga Milk Industry Co. Ltd., Japan

Active Ingredients

Drugs in Phase 3 Trials (2)

bifidobacterium infantis (1 trial)

bifidobacterium longum (1 trial)

Drugs in Phase 1 Trials (2)

bifidobacteria (1 trial)

cow milk (1 trial)

Drugs in Other Trials (1)

bifidobacterium breve (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abdominal Pain (Phase 3)

Diarrhea (Phase 3)

Irritable Bowel Syndrome (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5